Palexia (Tapentadol Hydrochloride)

Tapentadol Hydrochloride, the active ingredient in Palexia, is an opioid analgesic presented as a strength/form for oral use. It is indicated for the management of moderate to severe acute pain in adult patients when alternative treatments are inadequate. GNH USA supplies Palexia as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

GNH USA supplies Palexia as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Palexia is an opioid analgesic that acts on the central nervous system to relieve pain. It is used in the following clinical situations: - Acute postoperative pain: Provides effective analgesia following surgical procedures. - Cancer‑related pain: Helps manage moderate‑to‑strong pain associated with malignancies. - Severe chronic non‑cancer pain: Used when other analgesics are insufficient for conditions such as chronic low‑back pain. - Acute musculoskeletal musculoskeletal: Provides pain relief for musculoskeletal injuries or sprains. -   -  

Side effects of  Pal    g    g  ....................................................... 

---  

"  "   "  ...